Fabrizio Ganzina

A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia

Franco Mandelli, Maria Concetta Petti, Alfredo Ardia et al. · European Journal of Cancer and Clinical Oncology · 1991 · 100 citations

Hematological Malignancy, Oncology, Medicine +8

Idarubicin in the treatment of acute leukemias. An overview of preclinical and clinical studies.

Angelo Michele Carella, Ellin Berman, M. P. Maraone et al. · PubMed · 1990 · 56 citations

Mixed-phenotype Acute Leukemia, Immunology, Pharmacotherapy +19

Clinical Toxicity of 4′-Epi-Doxorubicin (Epirubicin)

Fabrizio Ganzina, Nicola Di Pietro, Osvaldo Magni · Tumori Journal · 1985 · 36 citations

Functional Assessment, Heart Failure, Oncology +15

Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncology

V. Tamassia, Agatino Battaglia, Fabrizio Ganzina et al. · Cancer Chemotherapy and Pharmacology · 1982 · 33 citations

Medroxyprogesterone Acetate, Oncology, Pharmacological Study +7

Phase II trial with oral idarubicin in advanced breast cancer

Massimo Lopez, Luigi Di Lauro, Paola Papaldo et al. · Investigational New Drugs · 1986 · 27 citations

Breast Oncology, Medicine, Pharmacology +6